J. Jasper Deuring

1.4k citations
20 papers · 767 · h-index 13

Impact in

Papers in

  • Genetics 11
    • Inflammatory Bowel Disease 8
    • Digestive system and related health 2
    • High Altitude and Hypoxia 1
  • Oncology 6
    • Drug Transport and Resistance Mechanisms 3
    • Cytokine Signaling Pathways and Interactions 3
Co-authors
C. Janneke van der Woude (11 shared papers)Colin de Haar (11 shared papers)Ernst J. Kuipers (10 shared papers)Maikel P. Peppelenbosch (11 shared papers)Yi Li (3 shared papers)Bing Xia (1 shared paper)Min Chen (1 shared paper)Monique M. Gerrits (1 shared paper)
Journals
PLoS ONE (2 papers)Inflammatory Bowel Diseases (2 papers)Gut (2 papers)The International Journal of Biochemistry & Cell Biology (1 paper)Carcinogenesis (1 paper)
Partner nations
NetherlandsUnited StatesUnited Kingdom

In The Last Decade

J. Jasper Deuring

18 papers receiving 751 citations

Peers

J. Jasper Deuring
Comparison fields: 5 of 79
  • Immunology 181
  • Genetics 245
  • Oncology 185
  • Cancer Research 79
  • Pharmacology 40
Replace G.C. Naccari with:
G.C. Naccari Italy
Norihiro Hamamoto Japan
Lydie Gioia‐Patricola France
Ken Toshina Japan
T. Witthoeft Germany
Leah M. Flick United States
Lianwen Yuan China
Lianjie Lin China
Ganglei Liu China
Dacheng Peng United States
J. Jasper Deuring relative to G.C. Naccari Italy G.C. Naccari's profile →
Citations per field
00.5×2×3×3.5×
G.C. Naccari · 1×
Citations per year

Countries citing papers authored by J. Jasper Deuring

Since Specialization
Citations

This map shows the geographic impact of J. Jasper Deuring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jasper Deuring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jasper Deuring more than expected).

Fields of papers citing papers by J. Jasper Deuring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jasper Deuring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jasper Deuring. The network helps show where J. Jasper Deuring may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Jasper Deuring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Jasper Deuring Line = papers co-authored together J. Jasper Deuring links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
Gut ·Yi Li, Colin de Haar, Min Chen, J. Jasper Deuring, Monique M. Gerrits, Ron Smits, Bing Xia, Ernst J. Kuipers, C. Janneke van der Woude
2009288
2
IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer
Carcinogenesis ·Yi Li, J. Jasper Deuring, Maikel P. Peppelenbosch, Ernst J. Kuipers, Colin de Haar, C. Janneke van der Woude
2012117
3
Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease
Gut ·J. Jasper Deuring, Gwenny M. Fuhler, Sergey R. Konstantinov, Maikel P. Peppelenbosch, Ernst J. Kuipers, Colin de Haar, C. Janneke van der Woude
2013108
4
Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding
Biochemical Journal ·J. Jasper Deuring, Colin de Haar, Chantal L Koelewijn, Ernst J. Kuipers, Maikel P. Peppelenbosch, C. Janneke van der Woude
201137
5
Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis—Patients’ and Physicians’ View
Inflammatory Bowel Diseases ·Marla C. Dubinsky, Kenji Watanabe, Pauliina Molander, Laurent Peyrin‐Biroulet, Michele Rubin, Gil Melmed, J. Jasper Deuring, John Woolcott, Joseph C. Cappelleri, Kathy Steinberg, Susan J. Connor
202133
6
Suppression of p21Rac Signaling and Increased Innate Immunity Mediate Remission in Crohn’s Disease
Science Translational Medicine ·Kaushal Parikh, Lu Zhou, Rajesh Somasundaram, Gwenny M. Fuhler, J. Jasper Deuring, Tjasso Blokzijl, Anouk Regeling, Ernst J. Kuipers, Rinse K. Weersma, Veerle J. Nuij, Maria M. Alves, Lauran Vogelaar, Lydia Visser, Colin de Haar, Kausilia K. Krishnadath, C. Janneke van der Woude, Gerard Dijkstra, Klaas Nico Faber, Maikel P. Peppelenbosch
201427
7
Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease
PLoS ONE ·J. Jasper Deuring, Meng Li, Wanlu Cao, Sunrui Chen, Wenshi Wang, Colin de Haar, C. Janneke van der Woude, Maikel P. Peppelenbosch
201927
8
Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians
Inflammatory Bowel Diseases ·David T. Rubin, Ailsa Hart, Remo Panaccione, Alessandro Armuzzi, Ulla Suvanto, J. Jasper Deuring, John Woolcott, Joseph C. Cappelleri, Kathy Steinberg, Laura Wingate, Stefan Schreiber
202026
9
The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease
The International Journal of Biochemistry & Cell Biology ·J. Jasper Deuring, Colin de Haar, Ernst J. Kuipers, Maikel P. Peppelenbosch, C. Janneke van der Woude
201320
10
STATI, STAT6 and Adenosine 3′,5′-Cyclic Monophosphate (cAMP) Signaling Drive SOCS3 Expression in Inactive Ulcerative Colitis
Molecular Medicine ·Yi Li, J. Jasper Deuring, Maikel P. Peppelenbosch, Ernst J. Kuipers, Colin de Haar, C. Janneke van der Woude
201218
11
Impeded protein folding and function in active inflammatory bowel disease
Biochemical Society Transactions ·J. Jasper Deuring, Maikel P. Peppelenbosch, Ernst J. Kuipers, C. Janneke van der Woude, Colin de Haar
201117
12
Analysis of SHIP1 expression and activity in Crohn’s disease patients
PLoS ONE ·Rajesh Somasundaram, Sandra Fernandes, J. Jasper Deuring, Colin de Haar, Ernst J. Kuipers, Lauran Vogelaar, Frank A. Middleton, C. Janneke van der Woude, Maikel P. Peppelenbosch, William G. Kerr, Gwenny M. Fuhler
201716
13
Dichotomal effect of space flight-associated microgravity on stress-activated protein kinases in innate immunity
Scientific Reports ·Auke P. Verhaar, Elmer Hoekstra, Angela S. W. Tjon, Wesley K. Utomo, J. Jasper Deuring, Elvira R. M. Bakker, Vanesa Muncan, Maikel P. Peppelenbosch
201415
14
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies
Therapeutic Advances in Gastroenterology ·Charlie W. Lees, J. Jasper Deuring, Michael Chiorean, Marco Daperno, Gianluca Bonfanti, Rebecca Germino, Pritha Bhadra Brown, Irene Modesto, Roger Edwards
20219
15
Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views
JGH Open ·Susan J. Connor, Alexandra Sechi, Mauricio Álvarez, J. Jasper Deuring, David Witcombe
20214
16
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program
Advances in Therapy ·Michael Chiorean, Marco Daperno, Charlie W. Lees, Gianluca Bonfanti, Dimitrios Soudis, Irene Modesto, J. Jasper Deuring, Roger Edwards
20232
17
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib
Arthritis Research & Therapy ·Merete Lund Hetland, Anja Strangfeld, Gianluca Bonfanti, Dimitrios Soudis, J. Jasper Deuring, Roger Edwards
20241
18
Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?
Current Therapeutic Research ·Samantha Howland, J. Jasper Deuring, Xiaofeng Zhou, Yan Chen, Lícia MH Mota, Ryan C. Ungaro
20211
19
ABCG2 protein down-regulation in active inflammatory bowel disease is due to incorrect protein folding
J. Jasper Deuring, Colin de Haar, Chantal L Koelewijn, Ernst J. Kuipers, Maikel P. Peppelenbosch, C. Janneke van der Woude
20111
20
Laboratory profiles of patients hospitalized with COVID-19 pneumonia treated with tofacitinib or placebo: a post hoc analysis from the STOP-COVID trial
Einstein (São Paulo) ·Patrícia O. Guimarães, Lucas Petri Damiani, Caio de Assis Moura Tavares, Ari Stiel Radu Halpern, J. Jasper Deuring, Luiz Vicente Rizzo, Otávio Berwanger
20240

About J. Jasper Deuring

J. Jasper Deuring is a scholar working on Genetics, Oncology, Surgery, Nutrition and Dietetics and Immunology, having authored 20 papers that have together received 767 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (8 papers), Drug Transport and Resistance Mechanisms (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Trace Elements in Health (3 papers), Digestive system and related health (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Pharmacological Effects of Natural Compounds (1 paper) and High Altitude and Hypoxia (1 paper). The work is most often cited by research in Immunology (181 citations), Genetics (245 citations), Oncology (185 citations), Cancer Research (79 citations) and Pharmacology (40 citations). J. Jasper Deuring has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include C. Janneke van der Woude, Colin de Haar, Ernst J. Kuipers, Maikel P. Peppelenbosch, Yi Li, Bing Xia, Min Chen, Monique M. Gerrits, Ron Smits and Gwenny M. Fuhler. Their work appears in journals such as PLoS ONE, Inflammatory Bowel Diseases, Gut, The International Journal of Biochemistry & Cell Biology and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.C. NaccariBreakdown of academic impact, for papers by Norihiro HamamotoBreakdown of academic impact, for papers by Lydie Gioia‐PatricolaBreakdown of academic impact, for papers by Ken ToshinaBreakdown of academic impact, for papers by T. WitthoeftBreakdown of academic impact, for papers by Leah M. FlickBreakdown of academic impact, for papers by Lianwen YuanBreakdown of academic impact, for papers by Lianjie LinBreakdown of academic impact, for papers by Ganglei LiuBreakdown of academic impact, for papers by Dacheng Peng